The SIN3A gene helps control when many other genes are switched on or off, which is important for brain development, growth, and learning. When one copy does not work properly, development can be affected and a person may have delayed speech, learning difficulties, short stature, or distinctive facial features. Pathogenic variants in the SIN3A gene cause Witteveen-Kolk syndrome, a developmental condition usually confirmed with genetic testing. It is mainly known in medical genetics rather than popular culture.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes provide the directions for making proteins, the parts of cells that do the work. Other genes are mainly involved in controlling when certain processes happen, where they take place, and how strongly they operate. Together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. If you want to go deeper into this topic, you can learn more in LearnHub.
Overview
SIN3AGene function
What if the gene works
The SIN3A gene helps control when other genes are turned on or off. This supports normal brain development and helps cells grow, divide, and mature in an organized way.
Risk
What if the gene does not work
More disruptive variants in the SIN3A gene are linked to Witteveen-Kolk syndrome, which often affects learning, speech, behavior, and growth. Milder variants may cause subtler features, while more severe variants can lead to earlier and more noticeable developmental differences.
Treatment
What does that mean for your treatment
For pathogenic variants in the SIN3A gene, no treatment or management approach specific to the SIN3A gene is currently established. Care is guided by a person’s symptoms and daily needs. The SIN3A gene is also being studied in cancer research as a possible biomarker and treatment target.
Conditions associated with SIN3A
Gene function
What if the gene works
Your cells need careful timing to decide which genes to use from moment to moment. The SIN3A gene supports that control by helping manage how tightly DNA is packed and how easily other genes can be read. Understanding SIN3A gene function helps show how cells keep growth, repair, and development on track.
The SIN3A gene helps cells control which other genes are active and which stay quiet. Its protein brings together helper proteins so this control can happen in an organized way.
It helps adjust how tightly DNA is wrapped around histones (proteins that DNA coils around). This changes how easily a cell can read selected genes when they are needed.
This gene helps cells switch groups of genes on or off at the right time. That supports steady cell growth, routine cell division, and normal development.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These differences are common and help make up normal human diversity, including variation in appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and simply reflect natural genetic variation. In some cases, though, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
The way SIN3A gene variants affect protein function often depends on the type of change. Many variants reduce the amount of SIN3A protein a cell can make or create a shortened protein that is cleared away early, while some missense variants change how the protein folds or binds to partner proteins. Milder variants may leave some activity, while more severe variants can remove most function and may be linked to earlier or more noticeable features in SIN3A-related conditions.
How variants are linked to conditions
Pathogenic variants in the SIN3A gene cause Witteveen-Kolk syndrome, a genetic condition linked to developmental delay, learning difficulties or intellectual disability, low muscle tone, short stature, and sometimes autism features or attention problems. In information about SIN3A gene conditions, this is the main well-established diagnosis. Some people also have a smaller head size, feeding difficulties, or mild facial differences, although features can vary from person to person.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widely found across the general population. Most do not directly affect health and simply reflect normal human variation. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences play a role. In some situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For SIN3A, risk is mostly determined by whether a disease-causing gene change is present, rather than by lifestyle or environmental factors. Most reported cases happen as a new change in the child, while having a parent with the same SIN3A change raises the chance of it happening in a family. There is not enough evidence to say that diet, exercise, or other daily habits lower this risk.
Inheritance of SIN3A variants
SIN3A-related conditions are inherited in an autosomal dominant pattern. This means a person with a disease-causing variant in one copy of the SIN3A gene can pass it to a child with a 50% chance in each pregnancy, regardless of the child’s sex. In many families, SIN3A inheritance starts with a new, de novo variant, meaning the change arose in the child and was not inherited from either parent. If a parent carries the variant, sons and daughters are equally able to inherit it.
What does my SIN3A result mean for my family?
For SIN3A, the main known condition is usually passed down in a dominant way, so close relatives such as a parent, brother, sister, or child may also carry the same result. Many SIN3A changes happen for the first time in one person and are not inherited from either parent, so a parent is not always the source. The family impact depends on whether the result was inherited or happened new in that person.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a SIN3A variant, genetic testing for SIN3A variants usually analyzes DNA from a blood or saliva sample using a multigene panel, exome sequencing, or genome sequencing. A lab reads the SIN3A gene's code, compares it with the usual sequence, and reports whether a variant is found and how it is classified.
When should I consider getting a genetic test?
Testing for SIN3A may be considered when a child has unexplained developmental delay, speech delay, learning problems, or autism features, especially with short stature or a small head size. It can also be relevant if a close family member has a known SIN3A variant or the same pattern of features.
A genetic result is only one part of your health story
Genetic test results can be informative, but how much they reveal varies by the condition and the type of variant involved. Over time, many other factors also influence how the body works, including lifestyle, environment, age, and medical history. For some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, genetic results may also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it through the body, or responds at the drug’s target. This helps explain why the same treatment works well for one person, seems weaker in another, or causes more side effects in someone else.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes affect the way people respond to medications. It studies patterns between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medications, genes influence either how strongly a drug works or how the body handles it. This information can support more informed and more individualized treatment decisions. More on this topic is available in the LearnHub.
Drugs influenced by the SIN3A gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or predicting medication response, so questions about medicines, side effects, or new symptoms are best discussed with your doctor.
History
SIN3A entered genetics through earlier work on the related SIN3 gene in yeast, where researchers were studying how cells switch other genes on and off. Building on this early work, scientists identified the human SIN3A gene as part of a broader effort to map genes involved in growth and development. Interest in SIN3A grew as laboratory studies connected it to core pathways that help guide early development. A major clinical milestone came in the 2010s, when genomic sequencing linked changes in the SIN3A gene to a neurodevelopmental condition now called Witteveen-Kolk syndrome. That finding gave families and clinicians a clearer explanation for a pattern of developmental and learning differences that had previously gone unnamed. Since then, research has continued to refine how different SIN3A variants relate to a person’s features and support needs.